Neumora Therapeutics, Inc.
Clinical trials sponsored by Neumora Therapeutics, Inc., explained in plain language.
-
New depression pill shows promise in Late-Stage trial
Symptom relief OngoingThis study tests an experimental oral drug, NMRA-335140, against a placebo in 332 adults with major depressive disorder. Over 6 weeks, researchers measure changes in depression symptoms using a standard rating scale. The goal is to see if the drug can safely reduce depression sev…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
New depression pill shows promise in large trial
Symptom relief OngoingThis study tests an experimental oral medication, NMRA-335140, against a placebo in 332 adults with major depressive disorder. Over 6 weeks, researchers measure changes in depression symptoms using standard rating scales. The goal is to see if the drug can safely reduce depressio…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC